Sanofi breaks into first-line multiple myeloma with FDA approval for Sarclisa

Sanofi breaks into first-line multiple myeloma with FDA approval for Sarclisa

Submitted by admin on September 22, 2024 - 9:44pm
Source: 
Fierce Pharma
News Tags: 
Sanofi
Sarclisa
FDA
Multiple Myeloma
Headline: 
Sanofi breaks into first-line multiple myeloma with FDA approval for Sarclisa
snippet: 

Since an initial FDA go-ahead in 2020, Sanofi’s Sarclisa has been specifically approved for patients with previously treated multiple myeloma. That changed Friday.

Do Not Allow Advertisers to Use My Personal information